Quality assurance procedures are essential in the maintenance of clinical standards in medicine. Conventional analysis techniques have difficulty in detecting gradual changes over time. Cumulative sum techniques monitor the frequency with which an event occurs and can detect changes in its frequency as soon as they become statistically significant. This study explores the use of cumulative sum techniques to monitor the performance of an acute pain team in a teaching hospital. It shows that periods of suboptimal performance can be readily identified. The prospective use of these techniques in clinical audit may allow the earlier identification and correction of technical or organisational problems. These should lead to improvements in patient care and satisfaction.
Audit is an essential part in the maintenance of standards in a clinical service. Standards are set in terms of treatment, outcomes, procedures and complications and the performance of the service is monitored both retro-and prospectively. Traditionally the data has been collected either retrospectively or prospectively and analysed en bloc after a defined period of time or number of events. This provides an assessment of the overall performance for that period of time.
Disadvantages of this traditional approach relate to the sample size and timing. Large samples take longer to collect and thus can delay identification of a change. Large samples will average out short-term variations in the data, masking significant transient changes. With small sample sizes there may be insufficient power to see significant change. Using subsets of data introduces the risk of selection bias into the analysis. In contrast, sequential testing allows continuous analysis of outcome without introducing errors due to sample selection.
Sequential tests of significance for use in medical quality control have been described 1, 2 . These tests are sometimes known as cumulative sum techniques (cusum) and are ideally suited to data that is collected serially. They have been used in medicine as indicators of performance and are particularly powerful in looking at changes that occur over time 3 . They permit rapid data analysis and the identification of trends in a series of data, which may reflect changes in performance of a clinical service. Continuous indicators of performance using sequential tests of significance may allow us to develop an early warning system to address suboptimal clinical performance to ensure the highest standards of patient care 3 . This paper describes how sequential test of significance can be used to develop a continuous performance indicator and how this may be applied to quality assurance of the acute pain team in a major teaching hospital.
THEORY
Serially collected data may be analysed using sequential tests of significance 4 . As each new piece of data is entered it is added to the trend and analysed. If a threshold is reached (determined in advance by the level of significance sought) then the test outcome becomes significant. If the predetermined threshold is not reached, then the observations remain inconclusive and further data may be added, unlike conventional analysis. With sufficient data the result attains significance and it is possible to either accept or reject the null hypothesis.
In practice, as each result comes to light, the value of a function of all the observations f(x) is plotted against the number of the observation (n). This may either be done graphically using boundary lines or mathematically using boundary points. The test compares the value of the f(x) for each serial observation with the appropriate limits in order to reach one of three decisions about the significance of the observations as described above. These tests can be applied to serial data to test for a difference in the mean, variance, proportion or frequency of an observation.
When the data is discrete and takes the form of an event that does or does not happen (i.e., success or failure), then the criterion of performance is the proportion of times the designated event occurs. We can thus use the sequential test of significance applied to testing for a difference in proportion (binomial test) as described by Davies 4 . If we collect whether a procedure is a success or failure then we can examine whether there are real changes in the proportion of failures over time.
When using sequential test for a difference in proportions, the function f(x) plotted is usually the total number of failures against the serial number of the observation/event. Failures and successes incur an increment of 1 and 0 respectively. It is necessary to define an unacceptable failure rate (p0) and an acceptable failure rate (p1) from which the boundary limits can be derived as described by Davies (see Appendix 1) . These are the standard proportions against which the data is compared sequentially. For each observation (n), the value of f(x) and the boundary limits can be calculated and the test applied either graphically or mathematically 4 . The formulae for calculating the boundary lines are given in Appendix 1.
Alternatively a scoring system can be used as described by Davies 4 . Instead of increasing the f(x) by 1 for each failure and 0 for a success, the origin of the results can be changed to s (see Appendix 1 for derivation of s) with a failure increasing f(x) by 1-s and a success decreasing f(x) by s. The boundary limits for the null and alternative hypothesis become h0 and h1 as defined in Appendix 1 and mathematically will therefore be the same for all values of n. If the values of the type 1 and type 2 errors (α, β) are chosen to be the same then, from Appendix 1 the value of h0 = -h1. The boundary lines (h0, h1) are therefore parallel and h0 is the same distance above as h1 is below the x-axis.
Sequential tests of significance terminate when the f(x) crosses a boundary line and either the null hypothesis or the alternative hypothesis is accepted. When the alternative scoring system of 1-s for a failure and -s for a success is used, the x-axis acts as the initial reference point/line and h0 (null hypothesis) and h1 (alternative hypothesis) represent the boundary lines above and below the axis. The test would normally end when the f(x) crosses h0 from below or h1 from above. Hence a decision would be made after that number of observations accepting either the null or the alternative hypothesis. However as the lines are parallel and equidistant from the x-axis, on the graph, we can draw further parallel lines above and below the x-axis at 2h0, 3h0, 4h0 and -2h1, -3h1, -4h1 etc. When f(x) crosses a boundary line a decision is made on the null or alternative hypothesis, however that boundary line is now redefined as the new reference point. The zero point (sequence start point) is effectively reset with the current boundary line regarded as the new reference line and the boundary lines above and below the new boundary limits for the null and alternative hypothesis for the next series of observations. This is the graphical equivalent of starting a new sequential test chart and mathematically is analogous to resetting the cumulative sum value to 0.
The adoption of the scoring system of 1-s and -s therefore allows the concatenation of successive sequential tests of significance for a change in proportions between defined acceptable and unacceptable failure rates for successive series of observations 1 .
METHODS
The Acute Pain Service at the Royal Perth Hospital is a consultant-led service. Patients on epidural or opioid infusion and patient-controlled analgesia (PCA) are visited at least once a day and reviewed to ensure optimum pain control in the postoperative period. An ongoing audit program collects data daily from each patient regarding the technique used and its associated complications, side-effects, efficacy and patient satisfaction. For each patient the reason for termination of the technique is recorded.
Data from all patients who had had an epidural infusion whilst on the acute pain service was extracted from the main acute pain database. These were sorted chronologically, based on the date of the original procedure. Entries into the termination field were analysed and the day and reason for termination of the epidural extracted.
For the purpose of the study, failure was defined as termination of the epidural due to inadequate analgesia, unacceptable side-effects, epidural site infection and catheter migration out of the space or other unspecified reasons as entered on the pain service audit form. Success was defined as termination due to resolution of pain or at the request of the patient, surgeon or anaesthetist for a reason other than one of the above constituting a failure.
The success or failure of an epidural was computed automatically by the database based on the definitions given above. We examined the overall success or failure of epidurals on the pain service and then looked more specifically at failure occurring in the first two postoperative days.
The chronological series of data consisting of the success or failure of individual epidurals was analysed conventionally and exported to a spreadsheet for sequential analysis as described above. Microsoft Excel (Excel 97, Microsoft Corp, WA, U.S.A.) was used to plot the sequential analysis graphs and corresponding boundary lines. The values for p0, p1, α and β could be altered and the graph redrawn automatically in order to look at performance based on different acceptable and unacceptable failure rate.
RESULTS
During the period May 97 to March 99, a total of 1245 epidural infusions were assessed by the acute pain service at Royal Perth Hospital. Of these, 156 (12.5%) had no termination codes entered into the database. A total of 1089 (87.5%) epidural procedures were therefore available for further analysis.
The reasons for termination are given in Table 1 . Overall there were a total of 409 failures as defined previously. This represents an overall failure rate of 37.6%. Twelve and a half per cent of epidurals were terminated due to inadequate analgesia and 10.5% due to catheter migration. Those terminated predominately at the request of the surgeon were 5.6%. Failures occurring on day 1 (173) represent a failure rate of 15.9%. Failures occurring on day 1 or 2 (297) represent a failure rate of 27.3% in the first two postoperative days.
The cumulative number of failures is shown in Figure 1 . The straight line suggests that there is a steady and consistent epidural failure rate. The conventional sequential test for a difference in the proportion of success or failures is shown in Figure 2 with appropriate boundary limits up to n=50. The acceptable and unacceptable failure rates were defined as 28% and 47% respectively as described in the discussion. The graph shows that the acceptable failure rate is reached after only 21 epidurals. Nothing further can be inferred from this graph as the test terminates once a boundary line is crossed.
The results from the sequential tests for a difference in proportion using the modified (1-s, -s) scoring system are shown in Figures 3, 4 and 5. These represent the overall success or failure of the epidurals (Figure 3) and also success or failure at day 1 ( Figure  4 1 or day 1 and 2 but had subsequently failed were regarded as successes on that particular day. Values for the acceptable (p1) and unacceptable (p0) failure rate are also shown for each graph. These graphs represent the performance of epidurals in terms of success or failure at the defined acceptable and unacceptable failure rates. The null hypothesis, that the observed failure rate is no different from the unacceptable failure rate, is accepted if the trend of the score is upwards and boundary lines are crossed from below. The alternative hypothesis, that the observed failure rate is no different from the acceptable failure rate, is accepted if the trend of the score is downwards and boundary lines are crossed from above. It must be remembered that if a boundary line is crossed, this becomes the new reference line and the new boundary lines are those above and below this line. It is this resetting of the reference line that allows the graph to continue monitoring the performance of the service. Periods of acceptable and suboptimal performance are clearly shown in all three graphs. The graphs are drawn using Microsoft Excel allowing the value of p0 and p1 to be altered at any stage. As performance improves, the standards for acceptable and unacceptable failure rates can be changed with the graphs being redrawn automatically.
The values of the α and β errors were equal for all examples shown above. The boundary lines are therefore parallel and equidistant from the reference allowing the test to be used as a continuous monitor of performance.
DISCUSSION
Quality assurance is an essential part of the efficient functioning of any clinical service. It ensures that patients receive the highest standard of healthcare possible. This study clearly demonstrates the hidden effects of time and periods of suboptimal performance in the acute pain service of a major teaching hospital 5 .
Over the period of 21 months approximately 60 epidurals per month were managed by the acute pain service. Data on the reason for termination was not available for 12.5% of cases. This may be due to technical problems with the method of collection or failure on the part of individuals collecting the data. This problem is being addressed by new and clearer data collection form which should ensure that all patients on the pain service have a termination code for the procedure recorded. Accurate data collection is essential for the effective audit of clinical practice. The overall failure rate for epidurals was high at 37%. Catheter migration out of the space represented a significant number of these, confirming the feeling of the acute pain team. A new catheter-securing device is currently being evaluated to reduce the problem. The reason for such a high number of terminations due to inadequate analgesia is not clear as until now there has been no mechanism for monitoring quality control in the pain service.
Analysis of the cumulative failure rate gives a false sense of security, as it appears that the overall failure rate is steady throughout the 21-month period due to the scale of the graph (Figure 1) . During an average two-month period approximately 100 epidurals are managed by the pain service. We would expect there to be about 37 failures during that period. Using the binomial distribution 6 and its estimated standard deviation, we can calculate that in any given two months where 100 epidurals are managed, the number of failures is likely to lie between 28 and 47 in 95% of cases (mean±2 SD). It is reasonable to use these values for the acceptable and non-acceptable failure rates to look at the hidden effects of time on the pain service epidural data. They represent two standard deviations from the current mean performance of the pain service based on an audit cycle of 100 epidurals.
Examination of the modified sequential analysis graph for the overall epidural failure rate clearly shows that between epidurals 0 and 300 the observed failure rate was no different from the acceptable failure rate as defined above (Figure 3 ). However between epidurals 300 and 700 there was a consistent period of suboptimal performance, with the cusum increasing, such that the observed failure rate was equal to or in excess of 47%, a value regarded as totally unacceptable. Following this, between epidurals 700 and 1000, there is a period of stability where no conclusion can be drawn, as the cumulative sum does not cross any boundary lines. The observed failure rate is therefore no better than 28% and no worse than 47%. The cumulative sum then starts to decrease once again, suggesting that the failure rate is again no different from the acceptable failure rate. Whereas the graph plotting the cumulative failure rate suggests a steady and consistent failure rate, the application of sequential analysis techniques clearly show that there are four phases in the performance of the service. Between epidurals 300 and 700, six unacceptable failure rate boundary lines are crossed. This represents statistically significant periods of poor performance which need further investigation. The technique is currently being adapted to run prospectively within the main acute pain database to allow the early detection of periods of poor performance requiring attention. Figures 4 and 5 show the results of applying the technique to the success or failure of epidurals on day 1 and days 1+2 combined. The selected values for p0 and p1 were calculated using the current mean failure rate for that set of data ± 2 standard deviations using the theoretical binomial distribution function for n=100 (Appendix 2). This number represents the average number of epidurals in a six to eight week period and is an appropriate audit cycle. Periods of poor performance are clearly identified by an upward trend in the cumulative sum crossing successive unacceptable failure rate boundary lines. Analysis of all the graphs shows that there are periods of unacceptably high failure rates for epidurals in the postoperative period. However the failure rate was significantly lower (15.9%) on the first postoperative day. The reasons for these changes in performance are unclear at present. They may represent changes in staff or technique over time. We are currently revising the dataset to try to identify the reasons for these changes in performance.
Cumulative sum methods have previously been used to monitor the quality of medical practice and in the assessment of training [1] [2] [3] . The method can be applied to individuals or groups when the criterion of performance is the proportion of time a designated event occurs and can be defined in terms of a success or failure. However it is often necessary to compare the observed proportion with some agreed standard proportion to determine whether the event is occurring to a greater or lesser extent. In this study we have used it to retrospectively monitor the performance of the acute pain service. It shows that it is possible to easily identify periods of poor performance that need further investigation. The graphical display of the trends and automatic computation of the boundary lines is easy to understand. The values for the acceptable and unacceptable failure rates were derived from the current mean performance of the service ± 2 standard deviations using the binomial distribution function for n=100. In the absence of any other standards and the criteria used to define success or failure, this was thought to be an acceptable starting point. Other methods for defining standards can be used. Indeed standards for acceptable failure rates may be derived from multi-centre studies. The values of p0 and p1 can altered to reflect particular subsets of data and allow a comparison of the performance between different units or groups to be made.
We are currently incorporating the technique into the main acute pain database. This will allow us to prospectively monitor the performance of the service and therefore recognize deterioration promptly. Sequential tests are designed to detect gradual deteriorations in performance. This continuous monitoring facility should alert us to deviations from acceptable standards that may reflect technical or organizational problems within the service that require attention. This system of prospective monitoring should improve the quality of care the acute pain team delivers to patients.
In conclusion, cumulative sum and sequential tests of significance are a simple statistical method that can be used to monitor performance in medicine. They provide a quantitative measure for audit that can be used both prospectively and retrospectively. The modified scoring system described by Davies allows the concatenation of sequential tests that can be viewed as a continuous monitor of performance. Where technical or organizational changes are made to address poor performance, the cumulative sum graph, with appropriately drawn boundary lines, is a powerful quantitative audit tool able to show whether a statistically significant improvement in performance has occurred. As standards improve, the changes can be viewed in the light of previous practice. We believe that this technique may have many uses in the quality control of medical practice.
Appendix 1
Formulae for the calculation of boundary lines for f(x) where x is the number of failures for sequential tests of significance for a difference in proportions (Binomial test). p0 = failure rate under the null hypothesis (unacceptable failure rate) p1 = failure rate under the alternative hypothesis (acceptable failure rate) α = risk of accepting a bad batch of observations β = risk of rejecting a good batch of observations If the type 1(α) and type 2 (β) errors are set to the same value then the value of h0 = -h1
The boundary limits are given by the formulae X0 = h0+ns (the upper boundary limit for the null hypothesis) X1 = h1+ns (the lower boundary limit for the alternative hypothesis) where h0 = -b/(P+Q) h1 = a/(P+Q) s = Q/(P+Q) P = ln p1/p0 Q = ln (1- 
p0)/(1-p1) a = ln (1-β)/α b = ln (1-α)/β
If the alternative scoring system proposed by Davies is adopted a failure is scored as 1-s and a success scored as -s. The upper boundary limit becomes h0 and the lower limit becomes h1. Therefore the boundary limits are the same for all values of n.
Appendix 2
For the binomial probability distribution, if the true proportion of events is p, then for a sample of size n:
The mean of the binomial distribution is np. The standard deviation of the distribution is the square root of npq where q=1-p.
The standard deviation of the proportion is the square root of (pq/n).
